| Primary |
| Hypercholesterolaemia |
17.8% |
| Blood Cholesterol Increased |
17.1% |
| Hypertension |
13.7% |
| Hyperlipidaemia |
10.3% |
| Acute Coronary Syndrome |
5.1% |
| Myocardial Ischaemia |
4.3% |
| Diabetes Mellitus |
4.1% |
| Blood Cholesterol |
3.8% |
| Coronary Artery Disease |
3.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Cardiovascular Event Prophylaxis |
2.2% |
| Dyslipidaemia |
2.1% |
| Prophylaxis |
2.1% |
| Atrial Fibrillation |
1.8% |
| Product Used For Unknown Indication |
1.7% |
| Depression |
1.7% |
| Angina Pectoris |
1.7% |
| Myocardial Infarction |
1.6% |
| Hypothyroidism |
1.5% |
| Pain |
1.1% |
|
| Rhabdomyolysis |
37.8% |
| Myalgia |
14.9% |
| Pain In Extremity |
6.4% |
| Myopathy |
3.6% |
| Muscle Spasms |
3.5% |
| Myositis |
3.1% |
| Muscular Weakness |
3.0% |
| Pain |
3.0% |
| Vomiting |
3.0% |
| Myocardial Infarction |
2.7% |
| Renal Failure Acute |
2.7% |
| Weight Decreased |
2.5% |
| Drug Interaction |
2.3% |
| Wrong Technique In Drug Usage Process |
2.0% |
| Renal Failure |
1.9% |
| Blood Creatine Phosphokinase Increased |
1.6% |
| Tendon Rupture |
1.6% |
| Drug Hypersensitivity |
1.5% |
| Cerebrovascular Accident |
1.4% |
| Drug Ineffective |
1.3% |
|
| Secondary |
| Blood Cholesterol Increased |
17.5% |
| Hypercholesterolaemia |
13.2% |
| Product Used For Unknown Indication |
12.5% |
| Hypertension |
11.2% |
| Drug Use For Unknown Indication |
9.9% |
| Hyperlipidaemia |
6.7% |
| Coronary Artery Disease |
3.5% |
| Myocardial Ischaemia |
3.5% |
| Diabetes Mellitus |
3.4% |
| Type 2 Diabetes Mellitus |
3.1% |
| Blood Cholesterol |
2.7% |
| Depression |
1.9% |
| Cardiac Disorder |
1.9% |
| Pain |
1.5% |
| Atrial Fibrillation |
1.4% |
| Cardiovascular Event Prophylaxis |
1.3% |
| Myocardial Infarction |
1.3% |
| Prophylaxis |
1.2% |
| Blood Triglycerides Increased |
1.2% |
| Ill-defined Disorder |
1.2% |
|
| Rhabdomyolysis |
22.4% |
| Myalgia |
12.8% |
| Drug Hypersensitivity |
7.1% |
| Pain In Extremity |
6.9% |
| Wrong Technique In Drug Usage Process |
5.9% |
| Vomiting |
5.4% |
| Weight Decreased |
4.5% |
| Pain |
4.0% |
| Muscle Spasms |
3.8% |
| Weight Increased |
3.2% |
| Myopathy |
3.1% |
| Pulmonary Embolism |
3.0% |
| Myocardial Infarction |
2.7% |
| Muscular Weakness |
2.6% |
| Myositis |
2.5% |
| Renal Failure Acute |
2.4% |
| Pancreatitis |
2.3% |
| Blood Creatine Phosphokinase Increased |
2.0% |
| Nausea |
1.9% |
| Overdose |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.6% |
| Drug Use For Unknown Indication |
15.5% |
| Hypertension |
10.7% |
| Blood Cholesterol Increased |
6.0% |
| Diabetes Mellitus |
5.5% |
| Depression |
4.3% |
| Pain |
4.3% |
| Osteoporosis |
3.3% |
| Rheumatoid Arthritis |
3.2% |
| Type 2 Diabetes Mellitus |
3.0% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Atrial Fibrillation |
2.6% |
| Anxiety |
2.1% |
| Blood Cholesterol |
2.0% |
| Arthritis |
2.0% |
| Cardiac Disorder |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Prophylaxis |
1.8% |
| Blood Pressure |
1.8% |
| Multiple Myeloma |
1.6% |
|
| Weight Decreased |
11.2% |
| Myocardial Infarction |
10.9% |
| Vomiting |
10.7% |
| Weight Increased |
8.2% |
| Nausea |
6.0% |
| Drug Ineffective |
5.2% |
| Pain |
4.8% |
| Type 2 Diabetes Mellitus |
4.3% |
| Vision Blurred |
4.3% |
| Death |
4.1% |
| Urinary Tract Infection |
3.7% |
| Renal Failure |
3.2% |
| Dyspnoea |
3.2% |
| Flushing |
3.1% |
| Transient Ischaemic Attack |
2.9% |
| Tremor |
2.9% |
| Pneumonia |
2.9% |
| Somnolence |
2.9% |
| Cerebrovascular Accident |
2.8% |
| Syncope |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
19.7% |
| Product Used For Unknown Indication |
15.6% |
| Hypertension |
8.2% |
| Hiv Infection |
6.6% |
| Hyperlipidaemia |
6.6% |
| Blood Cholesterol Increased |
4.9% |
| Blood Cholesterol |
4.1% |
| Diabetes Mellitus |
4.1% |
| Hypercholesterolaemia |
4.1% |
| Asthma |
3.3% |
| Dyslipidaemia |
3.3% |
| Blood Cholesterol Abnormal |
2.5% |
| Depression |
2.5% |
| Heart Transplant |
2.5% |
| Hypersensitivity |
2.5% |
| Lipids |
2.5% |
| Prophylaxis |
2.5% |
| Abstains From Alcohol |
1.6% |
| Arteriosclerosis |
1.6% |
| Atrioventricular Block |
1.6% |
|
| Rhabdomyolysis |
29.1% |
| Drug Interaction |
12.7% |
| Jaundice |
5.5% |
| Myalgia |
5.5% |
| Drug Ineffective |
3.6% |
| Feeling Abnormal |
3.6% |
| Haematoma |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Thrombophlebitis Superficial |
3.6% |
| Tricuspid Valve Incompetence |
3.6% |
| Upper Limb Fracture |
3.6% |
| Visual Disturbance |
3.6% |
| Vitamin B1 Increased |
3.6% |
| Vomiting |
3.6% |
| Aspartate Aminotransferase Increased |
1.8% |
| Asthenia |
1.8% |
| Back Pain |
1.8% |
| Blood Creatine Phosphokinase Increased |
1.8% |
| Discomfort |
1.8% |
| Drug Dose Omission |
1.8% |
|
